These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 11080194

  • 1. Kynurenine 3-hydroxylase inhibition in rats: effects on extracellular kynurenic acid concentration and N-methyl-D-aspartate-induced depolarisation in the striatum.
    Urenjak J, Obrenovitch TP.
    J Neurochem; 2000 Dec; 75(6):2427-33. PubMed ID: 11080194
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Neuroprotective potency of kynurenic acid against excitotoxicity.
    Urenjak J, Obrenovitch TP.
    Neuroreport; 2000 Apr 27; 11(6):1341-4. PubMed ID: 10817618
    [Abstract] [Full Text] [Related]

  • 4. Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus.
    Moroni F, Cozzi A, Carpendo R, Cipriani G, Veneroni O, Izzo E.
    Neuropharmacology; 2005 May 27; 48(6):788-95. PubMed ID: 15829251
    [Abstract] [Full Text] [Related]

  • 5. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
    Wu HQ, Rassoulpour A, Schwarcz R.
    J Neural Transm (Vienna); 2007 Jan 27; 114(1):33-41. PubMed ID: 16932989
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Modulation and function of kynurenic acid in the immature rat brain.
    Schwarcz R, Ceresoli-Borroni G, Wu HQ, Rassoulpour A, Poeggeler B, Hodgkins PS, Guidetti P.
    Adv Exp Med Biol; 1999 Jan 27; 467():113-23. PubMed ID: 10721048
    [Abstract] [Full Text] [Related]

  • 9. Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures.
    Carpenedo R, Meli E, Peruginelli F, Pellegrini-Giampietro DE, Moroni F.
    J Neurochem; 2002 Sep 27; 82(6):1465-71. PubMed ID: 12354294
    [Abstract] [Full Text] [Related]

  • 10. Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo.
    Beggiato S, Antonelli T, Tomasini MC, Tanganelli S, Fuxe K, Schwarcz R, Ferraro L.
    Eur J Neurosci; 2013 May 27; 37(9):1470-7. PubMed ID: 23442092
    [Abstract] [Full Text] [Related]

  • 11. Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.
    Bortz DM, Wu HQ, Schwarcz R, Bruno JP.
    Neuropharmacology; 2017 Jul 15; 121():69-78. PubMed ID: 28419874
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Determination of extracellular kynurenic acid in the striatum of unanesthetized rats: effect of aminooxyacetic acid.
    Speciale C, Wu HQ, Gramsbergen JB, Turski WA, Ungerstedt U, Schwarcz R.
    Neurosci Lett; 1990 Aug 14; 116(1-2):198-203. PubMed ID: 2259449
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum kynurenic acid is reduced in affective psychosis.
    Wurfel BE, Drevets WC, Bliss SA, McMillin JR, Suzuki H, Ford BN, Morris HM, Teague TK, Dantzer R, Savitz JB.
    Transl Psychiatry; 2017 May 02; 7(5):e1115. PubMed ID: 28463241
    [Abstract] [Full Text] [Related]

  • 17. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
    Foster AC, Kemp JA, Leeson PD, Grimwood S, Donald AE, Marshall GR, Priestley T, Smith JD, Carling RW.
    Mol Pharmacol; 1992 May 02; 41(5):914-22. PubMed ID: 1375317
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase.
    Chiarugi A, Carpenedo R, Molina MT, Mattoli L, Pellicciari R, Moroni F.
    J Neurochem; 1995 Sep 02; 65(3):1176-83. PubMed ID: 7643095
    [Abstract] [Full Text] [Related]

  • 19. Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities.
    Carpenedo R, Chiarugi A, Russi P, Lombardi G, Carlà V, Pellicciari R, Mattoli L, Moroni F.
    Neuroscience; 1994 Jul 02; 61(2):237-43. PubMed ID: 7969905
    [Abstract] [Full Text] [Related]

  • 20. Regulation of excitatory amino acid release by N-methyl-D-aspartate receptors in rat striatum: in vivo microdialysis studies.
    Bustos G, Abarca J, Forray MI, Gysling K, Bradberry CW, Roth RH.
    Brain Res; 1992 Jul 10; 585(1-2):105-15. PubMed ID: 1355000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.